Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Researchers of Pablo de Olavide University (Seville) study the behaviour of transgenic mice that simulate nervous diseases

next article
25.04.2006

Researchers of the Pablo de Olavide University (Seville)have started a project based on the study of phenotype techniques in mice and their applicability to the pharmaceutical industry and neurodegenerative medicine. It is a research conducted by the group ‘División de Neurociencias’, led by José María Delgado, that focuses on the development of new techniques for studying the behaviour and physiology of wild and transgenic mice’s nervous system.

 

The goal of this Excellence Project, funded by the Andalusian Ministry of Innovation, Science and Enterprise, is to have a full range of electrophysiological and behavioural techniques, available for contracting by the specialized pharmaceutical industry in order to study pro-cognitive drugs or the effects on the motor and sensorial human system as a previous stage for its possible application in patients with different diseases (Alzheimer-like dementias, affectation of the motor human system, ataxias, etc.).


As Prof. Delgado explained to Andalucía Investiga, ‘the study of the behaviour and cognitive capacities in mammals whose biology is very close to humans will allow possible clinic applications in the short or medium term’. In that respect, this group of experts has scientific links to some companies such as French company Syntelabo – Aventis or Spanish companies Cibertec and Kytos, which has scientific and technological collaboration agreements in regenerative medicine and psychopharmacology. One of the developed products, specifically a pro-cognitive drug of Syntelabo – Aventis, is now in its phase 2, that is, about to be launched into the market.

In this line, these researchers mix with different national and foreign groups of their field of specialisation. So far there are 16 groups interested in this project and their animals are going to undergo trials too.

Ismael Gaona | Source: alphagalileo
Further information: www.andaluciainvestiga.com

next article

More articles from Life Sciences:

nachricht Scientists watch as peptides control crystal growth with ‘switches, throttles and brakes’
25.11.2009 | DOE/Lawrence Livermore National Laboratory

nachricht Arsenic and Gold Clusters
25.11.2009 | Angewandte Chemie International Edition

All articles from Life Sciences >>>

B2B Search

Product / Service
Company / Organisation

Latest News

First black holes may have incubated in giant, starlike cocoons

25.11.2009 | Physics and Astronomy

KfW issues its first ever 7 year Euro-Benchmark

25.11.2009 | Business and Finance

Intelligence inside metal components

25.11.2009 | Information Technology

VideoLinks
More VideoLinks >>>

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News